The disappearing stent: When plastic replaces metal

Circulation

Volumn 125, Issue 19, 2012, Pages 2291-2294

  Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Editorials; stents

Indexed keywords

POLYLACTIC ACID;

ANGIOCARDIOGRAPHY; BARE METAL STENT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CRYSTALLIZATION; DEGRADATION; DEVICE THERAPY; DRUG ELUTING STENT; EDITORIAL; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; METAL STENT; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STENT;

ABSORBABLE IMPLANTS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LACTIC ACID; MALE; MYOCARDIAL REVASCULARIZATION; POLYMERS; STENTS;

EID: 84861228503     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.103911     Document Type: Editorial

References (17)

1. Schömig A, Kastrati A, Mudra H, Blasini R, Schühlen H, Klauss V, Richardt G, Neumann FJ. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation. 1994;90:2716-2724.
2. Aoki J, Ong AT, Rodriguez Granillo GA, McFadden EP, van Mieghem CA, Valgimigli M, Tsuchida K, Sianos G, Regar E, de Jaegere PP, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW. Full metal jacket" (stented length-64 mm) using drug eluting stents for de novo coronary artery lesions. Am Heart J. 2005;150:994-999. (Pubitemid 41613719)
3. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134-1140.
4. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, BoersmaE, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-678. (Pubitemid 46281313)
5. Zidar J, Lincoff A, Stack R. Biodegradable stents. In: Topol EJ, ed. Textbook of Interventional Cardiology. 2nd ed. Philadelphia, PA: Saunders; 1994;787-802.
6. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, and Uehata H. Initial and 6-month results of biodegradable poly-L-lactic acid coronary stents in humans. Circulation. 2000;102:399-404. (Pubitemid 30490677)
7. Nishio S, Kosuga K, Igaki K, Okada M, Kyo E, Tsuji T, Takeuchi E, Inuzuka Y, Takeda S, Hata T, Takeuchi Y, Kawada Y, Harita T, Seki J, Akamatsu S, Hasegawa S, Bruining N, Brugaletta S, de Winter S, Muramatsu T, Onuma Y, Serruys PW, Ikeguchi S. Long-term (10 years) clinical outcomes of first-in-human biodegradable poly-L-lactic acid coronary stents: Igaki-Tamai stents. Circulation. 2012;125: 2343-2352.
8. Dudek D, Onuma Y, Ormiston JA, Thuesen L, Miquel-Hebert K, Serruys PW. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention. 2012;7:1060-1061.
9. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897-910.
10. Abizaid A, Bartorelli AL, Whitbourn R, Clark L, Chevalier B, Miquel-Hebert K, Van Geuns RJ, Carrie D, Smits PC, Ormiston JA, McGreevy R, Seth A, Serruys PW Preliminary data from ABSORB EXTEND: a report of the 6-month clinical outcomes from the first 200 patients enrolled. J Am Coll Cardiol. 2011;58:B67.
11. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissman N, Waksman R; PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet. 2007;369:1869-1875.
12. Haude M, Erbel R, Verheye S, Waksman R, Weissman N, Degen H, Boese D, Erne P, Koolen J. Comparison of intermediate term late lume loss after coronary implantation of bare or pacitaxel eluting absorbable metal scaffolds: results from the PROGRESS-AMS and BIOSOLVE-1 trials. J Am Coll Cardiol. 2012;59:E203.
13. Palmerini T, Biondi-Zoccai G, Riva DD, Stettler C, Sangiorgi D, D'Ascenzo F, Kimura T, Briguori C, Sabatè M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379:1393-1402.
14. Brugaletta S, Garcia-Garcia HM, Onuma Y, Serruys PW. Everolimuseluting ABSORB bioresorbable vascular scaffold: present and future perspectives. Expert Rev Med Devices. March 16, 2012. doi: 10.1586/erd.12.17. http://www.expert- reviews.com. Accessed April 3, 2012.
15. Gomez-Lara J, Garcia-Garcia HM, Onuma Y, Garg S, Regar E, De Bruyne B, Windecker S, McClean D, Thuesen L, Dudek D, Koolen J, Whitbourn R, Smits PC, Chevalier B, Dorange C, Veldhof S, Morel MA, de Vries T, Ormiston JA, Serruys PW. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. J Am Coll Cardiol Cardiovasc Interv. 2010;3: 1190-1198.
16. Gomez-Lara J, Brugaletta S, Farooq V, Onuma Y, Diletti R, Windecker S, Thuesen L, McClean D, Koolen J, Whitbourn R, Dudek D, Smits PC, Chevalier B, Regar E, Veldhof S, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography. J Am Coll Cardiol Cardiovasc Interv. 2011;4:1271-1280.
17. Brugaletta S, Garcia-Garcia HM, Garg S, Gomez-Lara J, Diletti R, Onuma Y, van Geuns RJ, McClean D, Dudek D, Thuesen L, Chevalier B, Windecker S, Whitbourn R, Dorange C, Miquel-Hebert K, Sudhir K, Ormiston JA, Serruys PW. Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. Int J Cardiovasc Imaging. 2011;27:859-866.